Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Abstract 3210: Raptamer-drug conjugates as molecularly targeted cancer therapeutics

Stephanie P. Vega, Nancy E. Ward, Uksha Saini, Leniher Castan-Chibas, Garima Kaushik, Daniel Ciznadija, Dev Chatterjee, Michael J. Heffernan, Atul Varadhachary, Michael Ritchie

Cancer Res (2024) 84 (6_Supplement): 3210.

https://doi.org/10.1158/1538-7445.AM2024-3210

Published: 22 March 2024

View articletitled, Abstract 3210: Raptamer-drug conjugates as molecularly targeted cancer therapeutics

Journal Articles

Abstract 854: A pharmaco-pheno-multiomic integration analysis of pancreatic cancer: A highly predictive biomarker model of biomarkers of Gemcitabine/Abraxane sensitivity and resistance

Gilad Silberberg, Clare Killick-Cole, Yaron Mosesson, Haia Khoury, Xuan Ren, Mara Gilardi, Daniel Ciznadija, Paolo Schiavini, Marianna Zipeto, Michael Ritchie

Cancer Res (2023) 83 (7_Supplement): 854.

https://doi.org/10.1158/1538-7445.AM2023-854

Published: 04 April 2023

View articletitled, Abstract 854: A pharmaco-pheno-multiomic integration analysis of pancreatic cancer: A highly predictive biomarker model of biomarkers of Gemcitabine/Abraxane sensitivity and resistance

Journal Articles

Abstract 456: Raptamer-drug conjugates as molecularly targeted cancer therapeutics

Stephanie P. Vega, Dev Chatterjee, Atul Varadhachary, Michael Ritchie, Michael Heffernan, Daniel Ciznadija

Cancer Res (2023) 83 (7_Supplement): 456.

https://doi.org/10.1158/1538-7445.AM2023-456

Published: 04 April 2023

View articletitled, Abstract 456: Raptamer-drug conjugates as molecularly targeted cancer therapeutics

Journal Articles

Abstract 1599: Targeting tumor synthetic vulnerabilities and immune evasion mechanisms with CO-1002

Daniel Ciznadija, Gemechis Degaga, Abdul Mondal, Maxwell Hillbert, Cong Chen, Bikash Debnath, Sonam Mehrotra, Brandon Jones, Ralph Rivero, Kakajan Komurov

Cancer Res (2023) 83 (7_Supplement): 1599.

https://doi.org/10.1158/1538-7445.AM2023-1599

Published: 04 April 2023

View articletitled, Abstract 1599: Targeting tumor synthetic vulnerabilities and immune evasion mechanisms with CO-1002

Journal Articles

Abstract 1648: ImmunoGraft^® platform for the evaluation of Immuno-Oncology agents in PDX tumors models

David Cerna, Daniel Ciznadija, Bhavna Verma, David Sidransky, Evgeny Izumchenko, Angela Davies, Maria Mancini

Cancer Res (2017) 77 (13_Supplement): 1648.

https://doi.org/10.1158/1538-7445.AM2017-1648

Published: 01 July 2017

View articletitled, Abstract 1648: ImmunoGraft® platform for the evaluation of Immuno-Oncology agents in PDX tumors models

Journal Articles

Abstract 1836: Patient-derived xenograft (PDX) models expressing HER2 reflect clinical responses to targeted HER2 inhibition

Daniel Ciznadija, Amir Sonnenblick, Jennifer Jaskowiak, Angela Davies, David Sidransky

Cancer Res (2017) 77 (13_Supplement): 1836.

https://doi.org/10.1158/1538-7445.AM2017-1836

Published: 01 July 2017

View articletitled, Abstract 1836: Patient-derived xenograft (PDX) models expressing HER2 reflect clinical responses to targeted HER2 inhibition

Journal Articles

Abstract 3640: Validation of qBiomarker as an accurate and efficient mutation detection method in a comprehensive analysis of patient-derived tumor xenografts

Mariana Brait, Evgeny Izumchenko, Luciane Kagohara, Samuel Long, Piotr Wysocki, Brian Faherty, Elana Fertig, Tin Khor, Elizabeth Bruckheimer, Gilson Baia, Daniel Ciznadija, Ido Sloma, Ido Ben-Zvi, Keren Paz, David Sidransky

Cancer Res (2016) 76 (14_Supplement): 3640.

https://doi.org/10.1158/1538-7445.AM2016-3640

Published: 15 July 2016

View articletitled, Abstract 3640: Validation of qBiomarker as an accurate and efficient mutation detection method in a comprehensive analysis of patient-derived tumor xenografts

Journal Articles

Abstract 5031: A humanized mouse model for translational assessment of targeted immune checkpoint blockade

Gilson Baia, David Vasquez-Dunddel, Daniel Ciznadija, David Sidransky, Amanda Katz, Keren Paz

Cancer Res (2015) 75 (15_Supplement): 5031.

https://doi.org/10.1158/1538-7445.AM2015-5031

Published: 01 August 2015

View articletitled, Abstract 5031: A humanized mouse model for translational assessment of targeted immune checkpoint blockade

Journal Articles

Abstract 3219: A patient-centric repository of PDX models for translational oncology research

Tin O. Khor, Ido Ben Zvi, Amanda Katz, David Vasquez-Dunddel, Ido Sloma, Daniel Ciznadija, David Sidransky, Keren Paz

Cancer Res (2015) 75 (15_Supplement): 3219.

https://doi.org/10.1158/1538-7445.AM2015-3219

Published: 01 August 2015

View articletitled, Abstract 3219: A patient-centric repository of PDX models for translational oncology research

Journal Articles

Abstract P3-06-31: Patient-derived xenografts accurately predict patient response in breast cancer patients

Lisa Stow, Amanda Katz, Hanna Irie, Elisa Port, Justin Stebbing, Daniel Ciznadija, Angela Davies, Keren Paz

Cancer Res (2015) 75 (9_Supplement): P3-06-31.

https://doi.org/10.1158/1538-7445.SABCS14-P3-06-31

Published: 01 May 2015

View articletitled, Abstract P3-06-31: Patient-derived xenografts accurately predict patient response in breast cancer patients

Journal Articles

Abstract 1190: Multifactorial biological processes govern engraftment of patient-derived tumor tissue in immunodeficient mice

David M. Vasquez-Dunddel, Gilson Baia, Amanda Katz, Daniel Ciznadija, David Sidransky, Keren Paz

Cancer Res (2014) 74 (19_Supplement): 1190.

https://doi.org/10.1158/1538-7445.AM2014-1190

Published: 01 October 2014

View articletitled, Abstract 1190: Multifactorial biological processes govern engraftment of patient-derived tumor tissue in immunodeficient mice

Journal Articles

Abstract 1187: The Champions TumorGraft Bank: A demographically-rich repository of preclinical TumorGraft models

Tin Khor, David Vasquez, Amanda Katz, Gilson Baia, Daniel Ciznadija, David Sidransky, Keren Paz

Cancer Res (2014) 74 (19_Supplement): 1187.

https://doi.org/10.1158/1538-7445.AM2014-1187

Published: 01 October 2014

View articletitled, Abstract 1187: The Champions TumorGraft Bank: A demographically-rich repository of preclinical TumorGraft models

Journal Articles

Abstract 1674: Humanized mouse models for personalized preclinical testing of monoclonal antibodies targeting immune checkpoints

Gilson S. Baia, David Vasquez, Daniel Ciznadija, Brandy Wilkinson, David Sidransky, Amanda Katz, Keren Paz

Cancer Res (2014) 74 (19_Supplement): 1674.

https://doi.org/10.1158/1538-7445.AM2014-1674

Published: 01 October 2014

View articletitled, Abstract 1674: Humanized mouse models for personalized preclinical testing of monoclonal antibodies targeting immune checkpoints

Journal Articles

Cyclin D1 and Cdk4 Mediate Development of Neurologically Destructive Oligodendroglioma

Daniel Ciznadija, Yuhui Liu, Stephanie M. Pyonteck, Eric C. Holland, Andrew Koff

Cancer Res (2011) 71 (19): 6174–6183.

https://doi.org/10.1158/0008-5472.CAN-11-1031

Published: 29 September 2011

View articletitled, Cyclin D1 and Cdk4 Mediate Development of Neurologically Destructive Oligodendroglioma

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3210: Raptamer-drug conjugates as molecularly targeted cancer therapeutics

Abstract 854: A pharmaco-pheno-multiomic integration analysis of pancreatic cancer: A highly predictive biomarker model of biomarkers of Gemcitabine/Abraxane sensitivity and resistance

Abstract 456: Raptamer-drug conjugates as molecularly targeted cancer therapeutics

Abstract 1599: Targeting tumor synthetic vulnerabilities and immune evasion mechanisms with CO-1002

Abstract 1648: ImmunoGraft^® platform for the evaluation of Immuno-Oncology agents in PDX tumors models

Abstract 1836: Patient-derived xenograft (PDX) models expressing HER2 reflect clinical responses to targeted HER2 inhibition

Abstract 3640: Validation of qBiomarker as an accurate and efficient mutation detection method in a comprehensive analysis of patient-derived tumor xenografts

Abstract 5031: A humanized mouse model for translational assessment of targeted immune checkpoint blockade

Abstract 3219: A patient-centric repository of PDX models for translational oncology research

Abstract P3-06-31: Patient-derived xenografts accurately predict patient response in breast cancer patients

Abstract 1190: Multifactorial biological processes govern engraftment of patient-derived tumor tissue in immunodeficient mice

Abstract 1187: The Champions TumorGraft Bank: A demographically-rich repository of preclinical TumorGraft models

Abstract 1674: Humanized mouse models for personalized preclinical testing of monoclonal antibodies targeting immune checkpoints

Cyclin D1 and Cdk4 Mediate Development of Neurologically Destructive Oligodendroglioma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only